Home > Healthcare > Healthcare IT > Artificial Intelligence > AI in Epidemiology Market

AI in Epidemiology Market Analysis

Report ID: GMI5364
Published Date: Sep 2022
Report Format: PDF

Download Free Sample

AI in Epidemiology Market Analysis

Global Artificial Intelligence in Epidemiology Market Share By Deployment

Based on the mode of deployment, the artificial intelligence in epidemiology market is bifurcated into web-based and cloud-based segments. The web-based segment is poised to depict a CAGR of more than 26% through 2022-2030. The adoption of web-based software in epidemiology offers numerous benefits, including the ability to merge with other platforms that are interoperable. Web-based resources are also developed to provide health information quickly and support decision-making. Developments such as these will escalate the use of AI in web-based epidemiological data analysis.

In terms of applications, the AI in epidemiology market value from the disease & syndromic surveillance segment is anticipated to reach USD 1.8 billion by 2030. There is an increasing focus on monitoring and management of infectious and chronic diseases. Moreover, availability and high access to patient data are some of the benefits of AI across the application.

Global Artificial Intelligence in Epidemiology Market By End-use

Learn more about the key segments shaping this market

Download Free Sample

Based on end-users, the artificial intelligence in epidemiology market is categorized into healthcare providers, pharmaceutical and biotechnology companies, research labs, and government & state agencies. The research labs segment accounted for over 29% business share in 2021 and will be valued at over USD 935 million by 2030. An increase in the number of grants-in-aid and other support from governments has been observed, to carry out research studies and identify the knowledge gaps in the healthcare sector. Research labs are also using AI technology to conduct epidemiology studies and advance disease detection & prognosis.

Global Artificial Intelligence in Epidemiology Market By Region

Looking for region specific data?

Download Free Sample

North America artificial intelligence in epidemiology market is slated to exhibit a CAGR of 26.5% through 2030. The region has witnessed an escalating usage of AI solutions by federal agencies. The robust presence of major tech players, including Alphabet, IBM, Cerner Corporation, and Microsoft Corporation, will also foster efficient integration of AI in epidemiology. Countries like the U.S. and Canada boast of major pharmaceutical and biotechnology companies which investment significant amounts in research, representing strong potential for AI solution providers in North America.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Global artificial intelligence in epidemiology market was valued at over USD 310 million in 2021 and will exhibit a CAGR of more than 27% between 2022-2030, with increasing healthcare costs and the acceptance of digital platforms.

AI in epidemiology industry share from the research laboratories will be worth over USD 935 million by 2030, given the increasing grants-in-aid from governments to identify the knowledge gap in the healthcare sector.

North America artificial intelligence in epidemiology market is predicted to exhibit a CAGR of more than 26% through 2022-2030, on account of the escalating usage of AI solutions by federal agencies for public health management.

Cognizant Technology Solutions Corporation, Cerner Corporation (Oracle), Microsoft Corporation, Meditech, Siemens Healthineers AG, and SAS Institute, Inc. are some of the key companies holding a considerable portion of the market.